AptadelTx

Aptadel Therapeutics capta 2 M€ per desenvolupar el seu fàrmac contra el sarcoma d'Ewing ara.cat/economia/farma…

.@PCB_UB : @aptadel raises 2 million euros and prepares a new round to bring the project to the clinical phase stage biotech-spain.com/en/articles/ap…

. @aptadel Therapeutics raises 2 million euros and prepares a new round to bring the project to the clinical phase stage capital-riesgo.es/en/articles/ap…

🧬 La #innovación impulsa nuevas soluciones en el ámbito terapéutico 🤝Con #AyudasCDTI y los #FondosEuropeos #MRR impulsamos proyectos como el de @aptadel 🔬Desarrollo de una plataforma de aptámeros conjugados con #RNAS terapéuticos para nuevas estrategias frente al #cáncer 👉 aptadeltx.com 💡Apoyando con ayudas #NEOTEC: acortar.link/PGAvBD @CienciaGob @P_Recuperacion #AyudandoCrearFuturo #nextgenerationeu #MRR #PRTR #subvención #tecnología #innovación #salud #Agenda2030 #ODS3

🟢 Dr. Gisela Lorente, CEO, @aptadel 🟢 Dr. Héctor Pérez Montoyo, COO & Head of R&D, @AbilityPharma 🟢 @jordifabrega, Co-Founder & CEO, @ConnectaThx

@aptadel @TR_Qrem Tolemy bio The present and the future of biotech at @BIOSPAIN_AseBio #BIOSPAIN25

New investment in research on Ewing's sarcoma‼️ IDIBELL's spin-off @aptadel Therapeutics receives funding from @LittleWarriorFd to develop RNA-based molecules🧬to find alternative treatments that are more effective and less toxic than current ones More: idibell.cat/en/2025/01/new…

🟢 Top news of #CataloniaHealth on January 2025🔝 tuit.cat/be7Tm @_vitalera @aptadel @Ship2BVentures #WeAreCataloniaHealth

#canSERV_Userstories Adrian Torres is Head of R&D at @aptadel, which develops RNA-based therapeutics for paediatric cancers. With canSERV’s support, they are spearheading the clinical development. Explore how canSERV can advance YOUR own research. ➡️canserv.eu

List of approved RNA based drugs

#PCBCommunity | Gisela Lorente, cofounder & former CSO of @Aptadel is appointed new company CEO The #spinoff from @idibell_cat focuses on developing #RNAtherapies platform for #childhoodcancer using #aptamer technology @SRGIDIBELL @omt2007 @As_AlbaPerez pcb.ub.edu/en/gisela-lore…

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina 💬 Mercè de Frias, PhD, MBA, COO @OnaTherapeutics: “At the moment when we got awarded our team was growing. The program helped us consolidate it”.

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina @OnaTherapeutics 💬 Gisela Lorente, CSO @aptadel: “The program allowed us perform our own science and not having to rely that much in external sources”.

@aptadel @Dannabiotech @mimarkdx @zymvol @onechaintx @nmarti1212 @BIOSPAIN_AseBio @PCB_UB @barcelonactiva @bcn_ajuntament @RigauMarina @OnaTherapeutics 💬 Marina Rigau, CEO & Co-founder @mimarkdx: “I really appreciate the training offered by the program and specially the fact that trains the whole team and to just the C Levels”.

🔛 El programa #BCNHealthBooster és un èxit! 💬 María Terrades Palomar, CEO del @PCB_UB, ha confirmat a #BIOSPAIN2023 que "veient els indicadors destacats, és hora de començar a pensar en la propera edició del programa". Més detalls 👇🔗 biocat.cat/ca/noticies/le…

🗣️@nmarti1212 (#Biocat), ha conversat amb les representants de 3 de les startups seleccionades @OnaTherapeutics, @aptadel i @mimarkdx i ha assegurat que “al llarg dels propers dos anys, seguirem ajudant a les empreses a aconseguir el seu màxim potencial”

💡 In 2022 the accelerator selected 11 companies having impact projects: @aptadel, @Dannabiotech, Bioliquid Innovative Genetics, SL., deepull, GAT BIOSCIENCES S.L, GAT Therapeutics, @mimarkdx, Nuage Therapeutics, ONA Therapeutics, @zymvol Biomodeling & @onechaintx.

🔛 #BCNHealthBooster is a success! The program accelerates #health companies by offering access to a lab in the @PCB_UB & training by #Biocat 💬 María Terrades, DG of PCB, said at #BIOSPAIN2023 that "looking at the outstanding indicators, it's time to think in the next edition".

@montsebasora @PCB_UB Continuem amb una #taularodona moderada per Núria Martí, directora d'innovació de @biocat_cat. Debatem sobre el potencial del #BCNHealthBooster amb representants i referents del sector: 🔷 @mercedfs d'@OnaTherapeutics 🔷 @RigauMarina de @mimarkdx 🔷 Gisela Lorente d'@aptadel

@nmarti1212 @biocat_en @OnaTherapeutics 🟢 Marina Rigau @RigauMarina, CEO & Co-founder at @mimarkdx  🟢 Gisela Lorente, CSO at @aptadel  🟢 Speakers: María Terrades Palomar , Director of Innovation at @PCB_UB  📍 Speakers' corner 🕗 11,30 - 12,30 🔗biospain2023.org #BIOSPAIN2023 #AseBio #health #boost